Resources

Cardiovasular Risk Prediction Model

Articles:

Zhou, Bin, et al Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet, Volume 398, Issue 10304, 957 – 980 DOI: 1016/S0140-6736(21)01330-1 

Brewer KM, Grey C, Paynter J, Winter-Smith J, Hanchard S, Selak V, Ameratunga S, Harwood M. What are the gaps in cardiovascular risk assessment and management in primary care for Māori and Pacific people in Aotearoa New Zealand? Protocol for a systematic review. BMJ Open. 2022 Jun 8;12(6):e060145. doi: 1136/bmjopen-2021-060145. PMID: 35676004; PMCID: PMC9185566.

Wang TKM, Grey C, Jiang Y, et al Trends in cardiovascular outcomes after acute coronary syndrome in New Zealand 2006–2016 Heart 2021;107:571-577. https://heart.bmj.com/content/107/7/571

Sebastiano Barbieri, Suneela Mehta, Billy Wu, Chrianna Bharat, Katrina Poppe, Louisa Jorm, Rod Jackson, Predicting cardiovascular risk from national administrative databases using a combined survival analysis and deep learning approach, International Journal of Epidemiology, Volume 51, Issue 3, June 2022, Pages 931–944, https://doi.org/10.1093/ije/dyab258

Mehta S, Zhao J, Poppe K, Kerr AJ, Wells S, Exeter DJ, Selak V, Grey C, Jackson R. Cardiovascular risk management requires a combination of cardiovascular preventive pharmacotherapy and non-pharmacological interventions. Eur J Prev Cardiol. 2022 Sep 7;29(12):e312-e313. doi: 1093/eurjpc/zwac082. PMID: 35512449.

Pylypchuk R, Wells S, Kerr A, et al Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study. The Lancet, Volume 397, Issue 10291,2021, Pages 2264-2274, ISSN 0140-6736, https://doi.org/10.1016/S0140-6736(21)00572-9

Poppe KK, Doughty RN, Wells S, et al Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome Heart 2020;106:506-511. https://heart.bmj.com/content/106/7/506

Rod Jackson, Andrew Kerr, Sue Wells, ‘Should we reconsider the role of age in treatment allocation for primary prevention of cardiovascular disease?’ No, but we can improve risk communication metrics, European Heart Journal, Volume 38, Issue 20, 21 May 2017, Pages 1548–1552, https://doi.org/10.1093/eurheartj/ehw322

New Cardiac Pacemaker

Articles:

Shanks, J., Abukar, Y., Lever, N.A. et al. Reverse re-modelling chronic heart failure by reinstating heart rate variability. Basic Res Cardiol 117, 4 (2022). https://doi.org/10.1007/s00395-022-00911-0

Lim, G.B. Pacing with respiratory sinus arrhythmia improves outcomes in heart failure. Nat Rev Cardiol 19, 209 (2022). https://doi.org/10.1038/s41569-022-00681-1

Smart pacemaker adjusts your heartbeat with your breathing

Ghafouri, K. et al. The Use of Pacemaker Impedance Data for Breath-by-Breath Respiration Sensing. Heart, Lung and Circulation, Volume 31, S135 – S136. DOI: 10.1016/j.hlc.2022.06.203

Cardiac Inherited Disease Register

Articles:

Winbo A, Ramanan S, Eugster E, Rydberg A, Jovinge S, Skinner JR, Montgomery JM. Functional hyperactivity in long QT syndrome type 1 pluripotent stem cell-derived sympathetic neurons. Am J Physiol Heart Circ Physiol. 2021 Jul 1;321(1):H217-H227. Doi 10.1152/ajpheart.01002.2020. Epub 2021 Jun 18. PMID: 34142889.

D. Gelbart, N. Earle, J. Crawford, R. Stiles, T. Donoghue, A. Winbo, L. Marcondes, A. Martin, M.K. Stiles, J.R. Skinner. The Cardiac Inherited Disease Group’s Experience of Brugada Syndrome in New Zealand, Heart, Lung and Circulation, Volume 30, Supplement 2, 2021,Page S68, ISSN 1443-9506, DOI https://doi.org/10.1016/j.hlc.2021.05.024

D. Gelbart, N. Earle, R. Stiles, T. Donohughe, A. Winbo, L. Marcondes, A. Martin, M. Stiles, J. Skinner, Brugada Syndrome in New Zealand: The Experience of the National Cardiac Inherited Disease Group, Heart, Lung and Circulation, Volume 31, Supplement 1, 2022, Page S7, ISSN 1443-9506 https://doi.org/10.1016/j.hlc.2022.04.016

2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families  https://doi.org/10.1002/joa3.12449

Hypertension Research

Articles:

Talreja H, Tan J, Dawes M, Supershad S, Rabindranath K, Fisher J, Valappil S, van der Merwe V, Wong L, van der Merwe W, Paton J. A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019). N Z Med J. 2020 Apr 3;133(1512):85-87. PMID: 32242182. Read more here. 

D Gelbart, N. Earle, J. Crawford, R. Stiles, T. Donoghue, A. Winbo, L. Marcondes, A. Martin, M.K. Stiles, J.R. Skinner. The Cardiac Inherited Disease Group’s Experience of Brugada Syndrome in New Zealand, Heart, Lung and Circulation, Volume 30, Supplement 2, 2021, Page S68, ISSN 1443-9506, https://doi.org/10.1016/j.hlc.2021.05.024

Rheumatic Heart Disease Research

Articles:

Wilson N, Concannon A, Malcolm J, Davidakova S,  Martin W, Webb R, Moreland N, The Treatment of Acute Rheumatic Fever: Novel Use of Hydroxychloroquine. The Pediatric Infectious Disease Journal 39(7):p e120-e122, July 2020. | DOI: 10.1097/INF.0000000000002647

Bennett J, Zhang J, Leung W, et al. Rising Ethnic Inequalities in Acute Rheumatic Fever and Rheumatic Heart Disease, New Zealand, 2000–2018. Emerging Infectious Diseases. 2021;27(1):36-46. doi:10.3201/eid2701.191791.